Suchergebnisse - "Cilio, Giulia Luna"

PubPharm (17)

1

Correction : The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R&D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

ErratumFor: Drugs R D. 2022 Mar;22(1):1-8. - PMID 34921644

2

Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

3

Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

4

Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

5

Correction to : GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

ErratumFor: Infect Dis Ther. 2022 Apr;11(2):757-770. - PMID 35118580

6

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

7

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

8

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

9

GMMA Technology for the Development of Safe Vaccines : Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

ErratumIn: Infect Dis Ther. 2022 Jun;11(3):1313. - PMID 35435576

10

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials : The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R&D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

ErratumIn: Drugs R D. 2022 Sep;22(3):253. - PMID 35994226